Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used